These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13611260)

  • 1. The quantative effects of cations on erythrocyte agglutination by influenza virus vaccine.
    BOGERT AB; CORBETT JJ
    J Immunol; 1958 Dec; 81(6):524-6. PubMed ID: 13611260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the value of influenza virus vaccine in guinea pig].
    HENNEBERG G; WAGNER L
    Zentralbl Bakteriol Orig; 1953 Sep; 159(8):482-5. PubMed ID: 13123282
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The P/H reaction & its value for the diagnosis of the phases of the influenza virus].
    ALBALADEJO J; BERENGUER G
    Microbiol Esp; 1958; 11(2):119-33. PubMed ID: 13600034
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans.
    Tang JW; Ngai KL; Chan PK
    J Med Virol; 2008 Nov; 80(11):1992-6. PubMed ID: 18814271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
    Pushko P; Tumpey TM; Van Hoeven N; Belser JA; Robinson R; Nathan M; Smith G; Wright DC; Bright RA
    Vaccine; 2007 May; 25(21):4283-90. PubMed ID: 17403562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
    Atmar RL; Keitel WA; Patel SM; Katz JM; She D; El Sahly H; Pompey J; Cate TR; Couch RB
    Clin Infect Dis; 2006 Nov; 43(9):1135-42. PubMed ID: 17029131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the virus-host interrelationships. II. Blood group A substance and typhoid bacillus antigen as the inhibitor of influenzal hemagglutination.
    SHIRATORI T
    Yokohama Med Bull; 1953 Jun; 4(3):151-62. PubMed ID: 13137071
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [H5N1: vaccine solutions for humans and other animals].
    Durand MP
    Bull Acad Natl Med; 2006; 190(4-5):963-72. PubMed ID: 17195620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal DNA vaccine for influenza is immunogenic in humans.
    Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
    Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemagglutination by virus & its use in the demonstration of anti-influenza & anti-mumps viral antibiodies; tests on the antibody levels of population centers of Sardinia & Tuscany].
    PITZUS F
    Atti Accad Fisiocrit Siena Med Fis; 1957; 4():862-73. PubMed ID: 13535490
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influenza immunity titer in healthy persons].
    HENNEBERG G; WAGNER L
    Z Immun exp ther; 1954 Sep; 111(4):340-53. PubMed ID: 14349064
    [No Abstract]   [Full Text] [Related]  

  • 18. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I
    Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to influenza in older adults with chronic obstructive pulmonary disease.
    Gorse GJ; O'Connor TZ; Newman FK; Mandava MD; Mendelman PM; Wittes J; Peduzzi PN
    J Infect Dis; 2004 Jul; 190(1):11-9. PubMed ID: 15195238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.